Squawk on the Street
Goldman Crushes Estimates, Retail Sales Unexpectedly Rise, FDA Panel Backs Moderna Boosters
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Carl Quintanilla, Jim Cramer and David Faber began the show with a look at the last of the big banks reporting results, as Goldman Sachs crushed analysts’ estimates on strong investment banking and trading results. The firm produced $3.7 billion in investment banking revenue, an 88% increase from a year earlier. The anchors also hit retail sales increasing by 0.7% for the month of September compared to an estimated 0.2% decline. The increase came during a month when the government ended the enhanced benefits it had been providing during the Covid-19 pandemic and against forecasts that growth would slow in the third quarter due to the delta variant spread and a perceived pullback. Also in focus: An FDA Panel unanimously recommended Moderna Covid booster shots for at-risks adults. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.